Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome

References

• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106:1–7.
   Web of Science ®Google Scholar
• Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018;110(5):794–809.
   PubMed Web of Science ®Google Scholar
• Paschou SA, Polyzos SA, Anagnostis P, et al. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. Endocrine. 2020;67(1):1–8.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic Ovarian Syndrome (PCOS): long-term metabolic consequences. Metabol Clinic Exper. 2017:86:33–43.
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Farrokhi FR, Butler AE, et al. Insulin resistance: review of the underlying molecular mechanisms. J Cell Physiol. 2019;234(6):8152–8161.
   PubMed Web of Science ®Google Scholar
• Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest. 2021;44(2):233–244.
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
   PubMedGoogle Scholar
• Kheirollahi A, Teimouri M, Karimi M, et al. Evaluation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women. Lipids Health Dis. 2020;19:235.
   PubMed Web of Science ®Google Scholar
• Li M, Li L, Qin Y, et al. Elevated TyG index predicts incidence of contrast-induced nephropathy: a retrospective cohort study in NSTE-ACS patients implanted with DESs. Front Endocrinol (Lausanne). 2022;13:817176.
   PubMed Web of Science ®Google Scholar
• Huang R, Wang Z, Chen J, et al. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol. 2022;21(1):88.
   PubMed Web of Science ®Google Scholar
• Steven S, Frenis K, Oelze M, et al. Vascular Inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7092151.
   PubMed Web of Science ®Google Scholar
• The R E. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
   PubMed Web of Science ®Google Scholar
• Liu C, Ding L, Yang H, et al. Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome. Endocrine J. 2022;69(7):809–818.
   PubMedGoogle Scholar
• Alberti KG, Zimmet P, Shaw J, The metabolic syndrome–a new worldwide definition. Lancet. 2005;366(9491):1059–1062.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome–a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469–480.
   PubMed Web of Science ®Google Scholar
• Flegal KM. Body-mass index and all-cause mortality. Lancet. 2017;389(10086):2284–2285.
   PubMedGoogle Scholar
• Cameron AJ, Magliano DJ, Shaw JE, et al. The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol. 2012;41(2):484–494.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu C, Jin C, et al. Neck circumference is associated with hyperuricemia in women with polycystic ovary syndrome. Front Endocrinol. 2021;12:712855.
   PubMed Web of Science ®Google Scholar
• Bahadur A, Mundhra R, Kashibhatla J, et al. Prevalence of metabolic syndrome among women with different PCOS phenotypes – a prospective study. Gynecol Endocrinol. 2021;37(1):21–25.
   PubMed Web of Science ®Google Scholar
• Kar S. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: a prospective study of PCOS women. J Hum Reprod Sci. 2013;6(3):194–200.
   PubMedGoogle Scholar
• Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106(1):131–137.
   PubMed Web of Science ®Google Scholar
• Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339–352.
   PubMed Web of Science ®Google Scholar
• He Y, Lu Y, Zhu Q, et al. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. Am J Obstet Gynecol. 2019;221(2):138.e131–138.e112.
   Web of Science ®Google Scholar
• Cai Y, Chen B, Zeng X, et al. The triglyceride glucose index is a risk factor for enlarged perivascular space. Front Neurol. 2022;13:782286.
   PubMed Web of Science ®Google Scholar
• Gluvic Z, Zaric B, Resanovic I, et al. Link between metabolic syndrome and insulin resistance. Curr Vasc Pharmacol. 2017;15(1):30–39.
   PubMed Web of Science ®Google Scholar
• Park B, Lee HS, Lee YJ. Triglyceride glucose (TyG) index as a predictor of incident type 2 diabetes among nonobese adults: a 12-year longitudinal study of the Korean genome and epidemiology study cohort. Transl Res. 2021;228:42–51.
   PubMed Web of Science ®Google Scholar
• Wu TD, Fawzy A, Brigham E, et al. Association of triglyceride-glucose index and lung health: a population-based study. Chest. 2021;160:1026–1034.
   PubMed Web of Science ®Google Scholar
• Yang K, Liu W. Triglyceride and glucose index and sex differences in relation to major adverse cardiovascular events in hypertensive patients without diabetes. Front Endocrinol (Lausanne). 2021;12:761397.
   PubMed Web of Science ®Google Scholar
• Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15.
   PubMedGoogle Scholar
• Zhang X, Zhang T, He S, et al. Association of metabolic syndrome with TyG index and TyG-related parameters in an urban Chinese population: a 15-year prospective study. Diabetol Metab Syndr. 2022;14:84.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, et al. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab. 2007;18(7):280–285.
   PubMed Web of Science ®Google Scholar
• Teng MS, Wu S, Er LK, et al. LIPC variants as genetic determinants of adiposity status, visceral adiposity indicators, and triglyceride-glucose (TyG) index-related parameters mediated by serum triglyceride levels. Diabetol Metab Syndr. 2018;10:79.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu C, Jin C, et al. Neck circumference is associated with hyperuricemia in women with polycystic ovary syndrome. Front Endocrinol (Lausanne). 2021;12:712855.
   PubMed Web of Science ®Google Scholar
• Shi W, Xing L, Jing L, et al. Usefulness of triglyceride-glucose index for estimating hyperuricemia risk: insights from a general population. Postgrad Med. 2019;131(5):348–356.
   PubMed Web of Science ®Google Scholar